Want to see OVID full AI Analyst Report?
Ovid Therapeutics (OVID) Income Statement
Ovid Therapeutics Income Statement
Last quarter (Q2 2026), Ovid Therapeutics's total revenue was $733.00K, a decrease of 88.31% from the same quarter last year. In Q2, Ovid Therapeutics's net income was $-15.01M. See Ovid Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 7.25M | $ 566.00K | $ 392.00K | $ 1.50M | $ 208.38M | |
| $ 6.95M | $ 566.00K | $ 392.00K | $ 1.50M | $ 208.38M | |
| $ 49.39M | $ 62.45M | $ 59.67M | $ 57.05M | $ 84.17M | |
| Depreciation and Amortization | $ 273.00K | $ 613.00K | $ 568.00K | $ 1.38M | $ 237.08K |
| $ -17.14M | $ -57.77M | $ -57.01M | $ -54.17M | $ 124.45M | |
| $ -42.44M | $ -61.88M | $ -59.28M | $ -55.55M | $ 124.21M | |
| $ 25.02M | $ 35.45M | $ 6.94M | $ 1.38M | $ -45.69K | |
| $ -17.41M | $ -26.43M | $ -52.34M | $ -54.17M | $ 124.16M | |
| $ -17.41M | $ -26.43M | $ -52.34M | $ -54.17M | $ 122.83M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.24 | $ -0.37 | $ -0.74 | $ -0.77 | $ 1.78 |
| Diluted EPS | $ -0.24 | $ -0.37 | $ -0.74 | $ -0.77 | $ 1.76 |
| Weighted Average Shares Outstanding | 73.74M | 70.91M | 70.58M | 70.42M | 67.48M |
| Weighted Average Shares Outstanding (Diluted) | 73.74M | 70.91M | 70.58M | 70.42M | 68.07M |
Currency in USD
